Cyclooxygenase-2 and epithelial growth factor receptor up-regulation during progression of Barrett&rsquo;s esophagus to adenocarcinoma

doi:10.3748/wjg.v12.i6.928

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1682)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

198

HTML

1231

Figures (1-5)

144

Tables (1-1)

109

Sum=1682

Feb 14, 2006 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Feb 14, 2006; 12(6): 928-934
Published online Feb 14, 2006. doi: 10.3748/wjg.v12.i6.928

Table 1 Demographics of 104 study subjects with Barrett’s esophagus and 30 control subjects

	NB	SIM	I/LDG	HDG	EAC
Subjects	30	37	36	16	15
Gender (male:female)	28:2	34:3	30:6	14:2	14:1
Mean age (yr )	60	55	61	68	66
Short-segment CLE	27	21	7	1	0
Long-segment CLE	3	16	29	15	15

SIM: Specialized intestinal metaplasia; I/LGD: Indeterminate/low-grade dysplasia; HGD: High-grade dysplasia; EAC: Esophageal adenocarcinoma; NB: Nondetectable Barrett’s; CLE: Columnar-lined esophagus.

Citation: Li Y, Wo JM, Ray MB, Jones W, Su RR, Ellis S, Martin RCG. Cyclooxygenase-2 and epithelial growth factor receptor up-regulation during progression of Barrett’s esophagus to adenocarcinoma. World J Gastroenterol 2006; 12(6): 928-934
URL: https://www.wjgnet.com/1007-9327/full/v12/i6/928.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i6.928